Read + Share
Amedeo Smart
Independent Medical Education
Sfakianaki M, Papadaki C, Tzardi M, Trypaki M, et al. PKM2 expression as biomarker for resistance to oxaliplatin-based chemotherapy in colorectal cancer. Ann Oncol 2019;30 Suppl 4:iv21-iv22.PMID: 32085086
Email
LinkedIn
Facebook
Twitter
Privacy Policy